COPT5 (Copper Transporter 5) is a well-characterized protein involved in cellular copper homeostasis. Key findings include:
Function: Mediates copper transport across cellular membranes, particularly in vacuolar sequestration and redistribution .
Species: Studied in Arabidopsis thaliana (plant model) and Oryza sativa (rice) .
Antibody Availability: Commercial antibodies targeting COPT5 exist (e.g., for Western blotting), but none are designated "COPT5.2" .
Typographical Variations: "COPT5.2" may refer to:
A splice variant (e.g., COPT5-2), though no such isoforms are reported in literature.
A commercial clone designation (e.g., clone 5.2), but no suppliers list this product.
| Antibody Target | Host Species | Clonality | Applications | Source |
|---|---|---|---|---|
| COPT5 | Rabbit | Polyclonal | WB, IL | |
| UCP (Uncoupling Protein) | Rabbit | Polyclonal | WB, IL | |
| CD38 | Humanized | Monoclonal | Therapeutic |
Copper Transport: COPT5 facilitates copper mobilization from vacuoles during deficiency .
Iron Crosstalk: COPT5 mutants exhibit altered iron distribution, linking copper and iron metabolism .
Oxidative Stress: copt5 mutants show reduced SOD (superoxide dismutase) activity under copper deficiency .
| Parameter | Wild-Type | copt5 Mutant | Conditions |
|---|---|---|---|
| Cu/ZnSOD Activity | High | Low | Cu sufficiency |
| FeSOD1 Protein | Detectable | Undetectable | Cu deficiency |
| ROS Accumulation | Normal | Elevated | Fe deficiency |
While COPT5-specific antibodies are used in research, their validation requires:
Verify Terminology: Confirm if "COPT5.2" refers to a proprietary antibody clone or a newly discovered isoform.
Explore Homologs: Investigate antibodies against COPT5 homologs in other species (e.g., human CTR1).
Contact Manufacturers: Inquire with antibody suppliers (e.g., Agrisera, Abcam) for unpublished catalog entries.
COPT5 belongs to the solute carrier family 31 (SLC31) of metal transporters and plays a critical role in copper homeostasis, particularly in Arabidopsis thaliana. Unlike direct copper importers, COPT5 primarily functions in the mobilization of copper from internal stores under deficiency conditions. Research indicates that COPT5 participates in a complex crosstalk between copper and iron homeostasis pathways . When designing experiments to study COPT5, researchers should consider its distinct functional properties compared to other COPT family members, such as COPT2, which shows high induction under copper scarcity.
Antibodies targeting COPT proteins are invaluable tools that enable researchers to:
Visualize cellular and subcellular localization using immunohistochemistry (IHC-P) and immunocytochemistry/immunofluorescence (ICC/IF)
Monitor changes in protein expression under varying copper availability conditions
Investigate protein-protein interactions through co-immunoprecipitation approaches
Identify post-translational modifications that may regulate transporter activity
Correlate protein levels with transcriptional changes observed in microarray or RNA-seq studies
When selecting antibodies for COPT protein research, specificity validation is essential to ensure reliable experimental outcomes.
Based on available literature, commercial COPT antibodies (such as the COPT2 antibody ab238911) have been validated for the following applications :
Immunohistochemistry on paraffin-embedded sections (IHC-P), with successful detection in human gastric cancer tissue
Immunocytochemistry/Immunofluorescence (ICC/IF), with confirmed reactivity in HeLa cells using a 1/100 dilution followed by Alexa-Fluor®488-conjugated secondary antibody detection
Researchers should note that methodological optimization may be necessary when applying these antibodies to new experimental systems or tissue types.
COPT transporters play critical roles in metalloenzyme regulation, particularly for copper-dependent enzymes. Research in Arabidopsis has revealed that COPT5 influences the activity of superoxide dismutase (SOD) enzymes . In copt5 mutants under copper deficiency:
Cu/ZnSOD protein levels and enzymatic activity decrease significantly
FeSOD1 protein content and activity also show reduced levels, correlating with decreased mRNA expression
This impaired "SOD substitution" leads to exacerbated oxidative stress in the mutants
These findings highlight the importance of COPT-mediated copper transport in maintaining proper metalloenzyme function, particularly under nutrient-limited conditions.
Comprehensive investigation of the copper-iron homeostasis relationship can be approached through multiple experimental strategies:
Co-localization studies: Combine COPT antibodies with antibodies against iron transporters (NRAMP4, OPT3, YSL2, YSL3) to examine spatial relationships in cellular compartments.
Comparative expression analysis: Microarray data reveals that in copt5 mutants under copper deficiency, genes encoding iron transporters (OPT3, YSL2, YSL3, NRAMP4) are significantly upregulated . Researchers can use antibodies to determine if these transcriptional changes translate to altered protein levels.
Metalloenzyme activity assays: Monitor changes in activities of copper-dependent (Cu/ZnSOD) and iron-dependent (FeSOD) enzymes using in-gel activity assays in combination with immunoblotting .
Metal content analysis: Correlate COPT protein levels detected by immunoblotting with direct measurements of copper and iron content in different tissues and subcellular compartments.
Microarray analysis comparing wild-type and copt5 mutants under various copper conditions has revealed significant differential gene expression patterns . Under copper deficiency, the copt5 mutant shows upregulation of numerous metal transport genes:
| Locus | Short name | Description | copt5 +Cu/WT +Cu | copt5 −Cu/WT −Cu | WT −Cu/WT +Cu | copt5 −Cu/ copt5 +Cu |
|---|---|---|---|---|---|---|
| AT5G67330 | NRAMP4 | Natural resistance associated macrophage protein 4 | −1.14 | 1.86 | 1.27 | 2.69 |
| AT4G16370 | OPT3 | Oligopeptide transporter | −1.13 | 2.00 | 1.26 | 2.83 |
| AT3G46900 | COPT2 | Copper transporter 2 | −1.05 | 1.12 | 3.27 | 3.85 |
| AT4G30110 | HMA2 | Heavy metal atpase 2 | 1.05 | 1.35 | 2.16 | 2.77 |
| AT5G59030 | COPT1 | Copper transporter 1 | 1.06 | 1.36 | 1.25 | 1.60 |
| AT5G24380 | YLS2 | YELLOW STRIPE like 2 | 1.13 | 1.23 | 7.97 | 8.71 |
| AT5G53550 | YSL3 | YELLOW STRIPE like 3 | 1.14 | 1.37 | 2.09 | 2.52 |
Additionally, the copt5 mutant shows altered expression of genes involved in:
Reactive oxygen species (ROS) responses
Ethylene signaling pathways
Cellular carbohydrate metabolism
Sulfur and glucosinolate metabolic processes
This transcriptional reprogramming indicates that COPT5 influences multiple cellular processes beyond direct copper transport.
Ensuring antibody specificity is crucial for obtaining meaningful results. Researchers should implement the following validation approaches:
Western blotting with recombinant protein: Test reactivity against purified recombinant COPT protein versus related transporters.
Genetic knockout controls: Utilize samples from COPT knockout/knockdown models as negative controls, confirming loss of signal in these samples.
Peptide competition assays: Pre-incubate antibody with immunizing peptide to demonstrate blocking of specific binding.
Multiple antibody comparison: Validate findings using antibodies targeting different epitopes of the same protein when available.
Correlation with transcript levels: Compare protein detection patterns with known transcript expression profiles (as demonstrated in the copt5 mutant studies) .
Mass spectrometry verification: Confirm the identity of immunoprecipitated proteins to validate antibody specificity.
Research with the copt5 mutant reveals that COPT-mediated copper transport significantly impacts plant stress response mechanisms :
Oxidative stress management: The copt5 mutant shows impaired SOD activity under copper deficiency, indicating compromised ability to detoxify reactive oxygen species.
Metal deficiency responses: Transcriptomic analysis shows that COPT5 regulates numerous genes involved in metal ion transport and mobilization, affecting the plant's ability to respond to nutrient limitations.
Hormonal signaling: The copt5 mutant shows altered expression of genes involved in ethylene signaling and response pathways under copper deficiency.
Metabolic adaptations: Biological processes related to carbohydrate, sulfur, and glucosinolate metabolism are specifically modulated in the copt5 mutant, suggesting COPT5 influences metabolic adaptations to stress.
Researchers can use COPT antibodies to investigate how these stress response mechanisms correlate with changes in COPT protein levels and subcellular localization.
For successful immunodetection of COPT proteins, researchers should consider the following protocol parameters:
Immunocytochemistry/Immunofluorescence (ICC/IF):
Immunohistochemistry on paraffin-embedded sections (IHC-P):
Optimization considerations:
Test multiple fixation methods (paraformaldehyde, methanol, acetone)
Titrate antibody concentration to determine optimal signal-to-noise ratio
Evaluate different blocking solutions to minimize background
Based on published approaches, researchers can design comprehensive experiments to investigate COPT function during metal deficiency :
Time-course analyses: Monitor changes in COPT protein expression at multiple timepoints after inducing metal deficiency, correlating protein levels with transcriptional changes.
Comparative wild-type vs. mutant studies: Design experiments comparing wild-type and COPT-deficient systems under both sufficient and deficient conditions for multiple metals (copper, iron, zinc).
Subcellular fractionation approaches: Isolate different cellular compartments to track metal redistribution and COPT protein localization under deficiency conditions.
Functional assays: Measure activities of metalloenzymes (such as SODs) as functional readouts of metal availability and transport, correlating with COPT protein levels.
Double mutant analyses: Generate plants/cells deficient in both COPT and iron transporters (such as NRAMP3/4) to investigate functional relationships between these systems .
When designing experiments with COPT antibodies, researchers should incorporate the following controls:
Positive controls:
Samples with confirmed COPT expression (e.g., tissues known to express the target)
Recombinant COPT protein (when available)
Negative controls:
COPT knockout/knockdown samples (e.g., the copt5 mutant for COPT5 studies)
Secondary antibody-only controls to assess non-specific binding
Isotype controls to evaluate background from primary antibody
Validation controls:
Peptide competition assays
Multiple antibody comparison when possible
Correlation with mRNA expression data
Experimental condition controls:
Metal sufficiency vs. deficiency conditions
Treatment time-course to capture dynamic responses
Multiple biological replicates to ensure reproducibility
An integrated approach combining antibody detection with functional assays provides the most comprehensive understanding of COPT biology :
Correlation of protein levels with transport activity:
Detect COPT protein levels via immunoblotting
Measure copper content in relevant compartments
Correlate changes in protein abundance with altered metal distribution
Enzyme activity assays:
Use in-gel activity assays for metalloenzymes (e.g., SOD) as demonstrated in copt5 studies
Combine with immunoblotting to correlate enzyme protein levels with activity
Compare patterns between wild-type and COPT-deficient systems
Protein-protein interaction studies:
Use COPT antibodies for co-immunoprecipitation experiments
Identify interaction partners through mass spectrometry
Validate interactions through reciprocal co-immunoprecipitation or proximity ligation assays
Subcellular localization and trafficking:
Use immunofluorescence to track COPT localization under different metal conditions
Correlate localization changes with altered transport activity
Employ live-cell imaging with fluorescently-tagged constructs to complement antibody-based approaches
This comprehensive approach allows researchers to connect COPT protein dynamics directly to functional outcomes in metal transport and homeostasis.
The research on copt5 mutants demonstrates that transcript and protein levels don't always correlate perfectly . When faced with such discrepancies, researchers should:
Consider post-transcriptional regulation: Evaluate potential mechanisms including microRNA regulation, protein stability differences, or translational control.
Examine time-course dynamics: Transcript changes often precede protein-level changes, so temporal misalignment may explain apparent discrepancies.
Assess protein degradation pathways: Investigate whether altered ubiquitination or other degradation mechanisms affect protein stability.
Evaluate antibody sensitivity: Confirm that the detection method is sufficiently sensitive to capture subtle changes in protein abundance.
Examine subcellular redistribution: Determine if changes in protein localization rather than total abundance might explain functional differences.
When confronted with contradictory results in COPT research, consider these methodological approaches:
Multiple detection methods: Apply both antibody-based detection and alternative approaches (e.g., tagged constructs) to verify findings.
Genetic complementation: Restore COPT expression in knockout/knockdown systems to confirm phenotype rescue.
Physiological relevance assessment: Determine whether contradictions stem from in vitro versus in vivo conditions, as seen with COPT2 which "does not function as a copper(1+) importer in vivo" but "in vitro functions as a low-affinity copper(1+) importer" .
Species-specific differences: Consider whether contradictions reflect genuine biological differences between experimental systems or species.
Metal specificity validation: Verify that observed effects are specific to the metal of interest by testing multiple metal conditions and chelators.